Company / SG&A per Share
Medpace SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$6.45
FY2025
5-year range
$2.56 / $6.45
FY2021-FY2025
Trend
+10.1%
vs FY2024
Sector context
#66 of 156
Health Care
What the data says
At $6.45, Medpace's sg&a per share ranks #91 of 156 in the Health Care sector. SG&A per Share has increased for 3 consecutive years, from $2.56 in FY2022 to $6.45 in FY2025.
Based on SEC 10-K filings.
6.45 in FY2025 with a 5-year CAGR of +20.3%.
Increased from $5.19 to $6.45 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +36.1%
- 5-Year CAGR
- +20.3%
- 10-Year CAGR
- -
Sector benchmark
#91 of 156 in Health CareTop 58% of 156This company $6.45 Sector average $11421.53
▼
-99.9% below sector average
Key checks
Key Insights
- Medpace's sg&a per share has grown for 3 consecutive years.
- In FY2025, sg&a per share increased 10.1% year-over-year.
- Ranks #66 out of 156 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 147.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.45 | +10.1% |
| FY2024 | $5.86 | +12.9% |
| FY2023 | $5.19 | +102.8% |
| FY2022 | $2.56 | -16.2% |
| FY2021 | $3.05 | +19.5% |
| FY2020 | $2.56 | -4.3% |
| FY2019 | $2.67 | +54.0% |
| FY2018 | $1.73 | +11.3% |
| FY2017 | $1.56 | -17.4% |
| FY2016 | $1.89 | +3.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026